Outcome of Ewing sarcoma in a multidisciplinary setting in Lebanon

Bilal Abou Ali; Ralph Nader; Hani Tamim; Toufic Eid; Fouad Boulos; Nabil Khoury; Samir Akel; Rachid Haidar; Said Saghieh; Miguel Abboud; Samar Muwakkit; Hassan El-Solh; Raya Saab

doi:10.1002/pbc.24926

Outcome of Ewing sarcoma in a multidisciplinary setting in Lebanon

Bilal Abou Ali, Ralph Nader, Hani Tamim, Toufic Eid, Fouad Boulos, Nabil Khoury, Samir Akel, Rachid Haidar, Said Saghieh, Miguel Abboud, Samar Muwakkit, Hassan El-Solh, Raya Saab

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Treatment of Ewing sarcoma (ES) necessitates coordinated multi-disciplinary care. We analyzed outcome for 39 patients treated at a single institution in Lebanon, a developing country with available multidisciplinary treatment modalities, where financial barriers to care are overcome by a fundraising system. Median follow-up was 58 months. Five-year overall and event-free survival were 76% and 58%, respectively, for localized disease, and 40% and 38%, respectively, for metastatic disease. We conclude that, in a country with emerging economy, by following international protocols and ensuring availability of needed resources, outcome of patients with ES is similar to that in developed countries.

Original language	English
Pages (from-to)	1472-1475
Number of pages	4
Journal	Pediatric Blood and Cancer
Volume	61
Issue number	8
DOIs	https://doi.org/10.1002/pbc.24926
State	Published - Aug 2014

Keywords

Ewing sarcoma
Pediatric
Prognostic factors

Access to Document

10.1002/pbc.24926

Cite this

@article{da361d94e1ba4c4b996713d923b4f010,

title = "Outcome of Ewing sarcoma in a multidisciplinary setting in Lebanon",

abstract = "Treatment of Ewing sarcoma (ES) necessitates coordinated multi-disciplinary care. We analyzed outcome for 39 patients treated at a single institution in Lebanon, a developing country with available multidisciplinary treatment modalities, where financial barriers to care are overcome by a fundraising system. Median follow-up was 58 months. Five-year overall and event-free survival were 76% and 58%, respectively, for localized disease, and 40% and 38%, respectively, for metastatic disease. We conclude that, in a country with emerging economy, by following international protocols and ensuring availability of needed resources, outcome of patients with ES is similar to that in developed countries.",

keywords = "Ewing sarcoma, Pediatric, Prognostic factors",

author = "{Abou Ali}, Bilal and Ralph Nader and Hani Tamim and Toufic Eid and Fouad Boulos and Nabil Khoury and Samir Akel and Rachid Haidar and Said Saghieh and Miguel Abboud and Samar Muwakkit and Hassan El-Solh and Raya Saab",

year = "2014",

month = aug,

doi = "10.1002/pbc.24926",

language = "English",

volume = "61",

pages = "1472--1475",

journal = "Pediatric Blood and Cancer",

issn = "1545-5009",

number = "8",

}

TY - JOUR

T1 - Outcome of Ewing sarcoma in a multidisciplinary setting in Lebanon

AU - Abou Ali, Bilal

AU - Nader, Ralph

AU - Tamim, Hani

AU - Eid, Toufic

AU - Boulos, Fouad

AU - Khoury, Nabil

AU - Akel, Samir

AU - Haidar, Rachid

AU - Saghieh, Said

AU - Abboud, Miguel

AU - Muwakkit, Samar

AU - El-Solh, Hassan

AU - Saab, Raya

PY - 2014/8

Y1 - 2014/8

N2 - Treatment of Ewing sarcoma (ES) necessitates coordinated multi-disciplinary care. We analyzed outcome for 39 patients treated at a single institution in Lebanon, a developing country with available multidisciplinary treatment modalities, where financial barriers to care are overcome by a fundraising system. Median follow-up was 58 months. Five-year overall and event-free survival were 76% and 58%, respectively, for localized disease, and 40% and 38%, respectively, for metastatic disease. We conclude that, in a country with emerging economy, by following international protocols and ensuring availability of needed resources, outcome of patients with ES is similar to that in developed countries.

AB - Treatment of Ewing sarcoma (ES) necessitates coordinated multi-disciplinary care. We analyzed outcome for 39 patients treated at a single institution in Lebanon, a developing country with available multidisciplinary treatment modalities, where financial barriers to care are overcome by a fundraising system. Median follow-up was 58 months. Five-year overall and event-free survival were 76% and 58%, respectively, for localized disease, and 40% and 38%, respectively, for metastatic disease. We conclude that, in a country with emerging economy, by following international protocols and ensuring availability of needed resources, outcome of patients with ES is similar to that in developed countries.

KW - Ewing sarcoma

KW - Pediatric

KW - Prognostic factors

UR - http://www.scopus.com/inward/record.url?scp=84901989831&partnerID=8YFLogxK

U2 - 10.1002/pbc.24926

DO - 10.1002/pbc.24926

M3 - Article

C2 - 24395458

AN - SCOPUS:84901989831

SN - 1545-5009

VL - 61

SP - 1472

EP - 1475

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

IS - 8

ER -

Outcome of Ewing sarcoma in a multidisciplinary setting in Lebanon

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this